Fangzhou Inc. (方舟健客, 6086.HK) is China’s leading online chronic disease management platform. We commenced our business with a focus on chronic
disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. Leveraging our chronic disease management platform, we are dedicated to providing tailored medical care and precision medicine for a growing population of chronic disease patients.
Company Details
- Employees
- 191
- Founded
- 2015
- Address
- Huangpu District, Guangzhou,guangdong 00000,china
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.jianke.com
- Keywords
- IT Consulting.
- HQ
- Guangzhou, Guangdong
Fangzhou Inc. (方舟健客 6086.hk) Questions
Fangzhou Inc. (方舟健客 6086.Hk)'s website is http://www.jianke.com
Fangzhou Inc. (方舟健客 6086.Hk)'s LinkedIn profile is https://cn.linkedin.com/company/jianke
Fangzhou Inc. (方舟健客 6086.Hk) has
191 employees.
View email and phone details for 191
employees at Fangzhou Inc. (方舟健客 6086.Hk).
Fangzhou Inc. (方舟健客 6086.Hk)'s industry is
Hospitals and Health Care
Fangzhou Inc. (方舟健客 6086.Hk)'s top competitors are
Nhs,
Health2sync 智抗糖,
Cognitant Group Limited,
Novo Nordisk,
Modella Ai,
Prosoma,
Gero,
Everex,
Sanofi,
Ōura.
Fangzhou Inc. (方舟健客 6086.Hk)'s categories are Hospitals and Health Care
Fangzhou Inc. (方舟健客 6086.Hk)'s founding year is 2015
